FARMAE S.P.A.
Talea Group S.p.A. operates as an e-retailer of health, wellness, and beauty products in Italy. It operates through two segments: Consumers Area and Industrial Area. The Consumer Area segment offers cosmetics; hair products; skincare; make up and fragrances; supplements/dietary products; over-the-counter medicines; medical devices; electromedical equipment; hygiene and wellness; mother- and child… Read more
Market Cap & Net Worth: FARMAE S.P.A. (U5Y)
FARMAE S.P.A. (F:U5Y) has a market capitalization of $38.77 Million (€37.77 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #25521 globally and #2796 in its home market, demonstrating a -1.77% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying FARMAE S.P.A.'s stock price €4.45 by its total outstanding shares 8486837 (8.49 Million).
FARMAE S.P.A. Market Cap History: 2022 to 2026
FARMAE S.P.A.'s market capitalization history from 2022 to 2026. Data shows change from $94.61 Million to $38.77 Million (-30.11% CAGR).
FARMAE S.P.A. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how FARMAE S.P.A.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of U5Y by Market Capitalization
Companies near FARMAE S.P.A. in the global market cap rankings as of March 19, 2026.
Key companies related to FARMAE S.P.A. by market ranking:
- Alibaba Health Information Technology Limited (PINK:ALBBY): Ranked #1435 globally with a market cap of $12.50 Billion USD.
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #1880 globally with a market cap of $8.58 Billion USD.
- Raia Drogasil S.A (SA:RADL3): Ranked #2749 globally with a market cap of $5.08 Billion USD ( R$30.91 Billion BRL).
- Clicks Group Ltd (PINK:CLCGY): Ranked #2859 globally with a market cap of $4.80 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1435 | Alibaba Health Information Technology Limited | PINK:ALBBY | $12.50 Billion | $12.32 |
| #1880 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $8.58 Billion | $11.98 |
| #2749 | Raia Drogasil S.A | SA:RADL3 | $5.08 Billion | R$23.58 |
| #2859 | Clicks Group Ltd | PINK:CLCGY | $4.80 Billion | $35.11 |
FARMAE S.P.A. Historical Marketcap From 2022 to 2026
Between 2022 and today, FARMAE S.P.A.'s market cap moved from $94.61 Million to $ 38.77 Million, with a yearly change of -30.11%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €38.77 Million | 0.00% |
| 2025 | €38.77 Million | +3.25% |
| 2024 | €37.55 Million | -47.69% |
| 2023 | €71.78 Million | -24.13% |
| 2022 | €94.61 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of FARMAE S.P.A. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $38.77 Million USD |
| MoneyControl | $38.77 Million USD |
| MarketWatch | $38.77 Million USD |
| marketcap.company | $38.77 Million USD |
| Reuters | $38.77 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.